CClinicalTrials.gg
Sign In
WithdrawnNCT00583648Updated May 13, 2016

Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?

An interventional study of Urinanlysis in Urinary Tract Infections, sponsored by University of California, Los Angeles. Withdrawn at 1 site in United States. Open to participants aged 16 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-05-13.

Sponsored by University of California, Los Angeles · Not applicable and Interventional

Why this study was withdrawn
lack of funding
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
16 Years to 65 Years
Sex
All
01

Study summary

The implementation of nursing urinanlysis protocols based off of symptoms of urinary infections will significantly decrease the length of a patient's stay in the Emergency Department.

02

Conditions studied

  • Urinary Tract Infections

Keywords

  • urinary tract infections
  • urine
  • urinalysis
  • urine protocols
  • urinalysis protocols
  • nursing protocols
  • Emergency Department
03

In context

Urinary Tract Infections

753 studies on the registry are indexed under Urinary Tract Infections; 128 are open to participants now.

Browse Urinary Tract Infections studies →

Lead sponsor

University of California, Los Angeles is the lead sponsor of 1,142 studies on the registry; 192 are open to participants now.

Of its 91 completed or terminated interventional studies of FDA-regulated products, 66 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • patients between 16 and 65 years of age complaining of any of the following: dysuria, hematuria, urinary frequency, urinary urgency

Exclusion criteria

Exclusion Criteria:

  • any person less than 16 or greater than 65 years of age, history of kidney disease or transplant, foley catherization within the last 30 days, on immuno-suppresent and/or receiving chemotherapy
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    1

    Recieves urinalysis by nurse per set protocol based off of inclusion criteria

    Other: Urinanlysis

  • No intervention
    2

    ordering of test will be up to the treating physician

Interventions

  • OtherUrinanlysis

    sending a Urine sample to the laboratory for processing

    Also known as: UA

06

What researchers measure

Primary outcomes

  1. Length of Stay in the Emergency Department

    Time frame: 1 hour

Secondary outcomes

  1. Physician decision making on ordering urinalysis based off of chief complaints

    Time frame: 1 hour

07

Study locations

1 site
  • University of California, Los Angeles Medical Center
    Los Angeles, California 90095, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00583648
Lead sponsor
University of California, Los Angeles
Responsible party
David Schriger (Principal Investigator, University of California, Los Angeles) — Principal investigator
First posted
Dec 31, 2007
Start date
Feb 2008
Completion
Feb 2009 (estimated)
Last update
May 13, 2016

Study contacts

Andrew W Seefeld, M.D.
principal investigator · University of California, Los Angeles

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Urinary Tract Infections→

Other studies from this sponsor

University of California, Los Angeles

Start the discussion